Cargando…
ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source
Mitochondria in cancer cells maintain a more negative membrane potential than normal cells. Mitochondria are the primary source of cellular reactive oxygen species (ROS), which are necessary for photodynamic therapy. Thus, the strategy of targeting mitochondria can maximize the photodynamic therapeu...
Autores principales: | Yue, Caixia, Yang, Yuming, Zhang, Chunlei, Alfranca, Gabriel, Cheng, Shangli, Ma, Lijun, Liu, Yanlei, Zhi, Xiao, Ni, Jian, Jiang, Weihua, Song, Jie, de la Fuente, Jesús M., Cui, Daxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118600/ https://www.ncbi.nlm.nih.gov/pubmed/27877240 http://dx.doi.org/10.7150/thno.15433 |
Ejemplares similares
-
Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy
por: Yue, Caixia, et al.
Publicado: (2016) -
Tumor-triggered drug release from calcium carbonate-encapsulated gold nanostars for near-infrared photodynamic/photothermal combination antitumor therapy
por: Liu, Yanlei, et al.
Publicado: (2017) -
Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers
por: Sun, Chun-Yang, et al.
Publicado: (2018) -
A tumor microenvironment responsive biodegradable CaCO(3)/MnO(2)- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy
por: Liu, Yanlei, et al.
Publicado: (2019) -
ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy
por: Wan, Zhuo, et al.
Publicado: (2022)